The path to healthy ageing in China: a Peking University–Lancet CommissionXinxin Chen, Yaohui Zhao, John Giles et al.|The Lancet|2022Cited by 900
Trends in Chronic Kidney Disease in ChinaLuxia Zhang, Haibo Wang, Jianyan Long et al.|New England Journal of Medicine|2016Cited by 796
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines AgencyAndrew S. Levey, Kerry Willis, Kai‐Uwe Eckardt et al.|American Journal of Kidney Diseases|2019Cited by 561
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysisBakhtawar K. Mahmoodi, Brad C. Astor, Kunihiro Matsushita et al.|The Lancet|2012Cited by 444
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysisCsaba P. Kövesdy, H. Lester Kirchner, Kunihiro Matsushita et al.|European Heart Journal|2018Cited by 323